Home > > > > > Report Detail

Global Alcohol Addiction Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 06-Oct-2022
No. of pages: 115
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Alcohol Addiction Therapeutics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Alcohol Addiction Therapeutics market. Further, it explains the major drivers and regional dynamics of the global Alcohol Addiction Therapeutics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- AstraZeneca Plc

- BioCorRx Inc

- Bionex Pharmaceuticals LLC

- Cerecor Inc

- Chronos Therapeutics Ltd

- Corcept Therapeutics Inc

- Curemark LLC

- Eli Lilly and Company

- Ethypharm SA

- H. Lundbeck A/S

- Heptares Therapeutics Ltd

- Indivior Plc

- Kinnov Therapeutics SAS

- Kyorin Pharmaceutical Co Ltd

- Lohocla Research Corp

- Montisera Ltd

- Omeros Corp

- Opiant Pharmaceuticals Inc

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Alcohol Addiction Therapeutics Segment by Type

- CM-1212

- CTDP-002

- A-705253

- ABT-436

- ADX-71441

- Others

Alcohol Addiction Therapeutics Segment by Application

- Hospital

- Clinic

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Alcohol Addiction Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Alcohol Addiction Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Alcohol Addiction Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Alcohol Addiction Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alcohol Addiction Therapeutics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Alcohol Addiction Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Alcohol Addiction Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including AstraZeneca Plc, BioCorRx Inc, Bionex Pharmaceuticals LLC, Cerecor Inc, Chronos Therapeutics Ltd, Corcept Therapeutics Inc, Curemark LLC, Eli Lilly and Company and Ethypharm SA, etc.

Global Alcohol Addiction Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 CM-1212
1.2.3 CTDP-002
1.2.4 A-705253
1.2.5 ABT-436
1.2.6 ADX-71441
1.2.7 Others
1.3 Market by Application
1.3.1 Global Alcohol Addiction Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Alcohol Addiction Therapeutics Market Size (2017-2028)
2.2 Alcohol Addiction Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Alcohol Addiction Therapeutics Market Size by Region (2017-2022)
2.4 Global Alcohol Addiction Therapeutics Market Size Forecast by Region (2023-2028)
2.5 Global Top Alcohol Addiction Therapeutics Countries Ranking by Market Size
3 Alcohol Addiction Therapeutics Competitive by Company
3.1 Global Alcohol Addiction Therapeutics Revenue by Players
3.1.1 Global Alcohol Addiction Therapeutics Revenue by Players (2017-2022)
3.1.2 Global Alcohol Addiction Therapeutics Market Share by Players (2017-2022)
3.2 Global Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Alcohol Addiction Therapeutics Revenue
3.4 Global Alcohol Addiction Therapeutics Market Concentration Ratio
3.4.1 Global Alcohol Addiction Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alcohol Addiction Therapeutics Revenue in 2021
3.5 Global Alcohol Addiction Therapeutics Key Players Head office and Area Served
3.6 Key Players Alcohol Addiction Therapeutics Product Solution and Service
3.7 Date of Enter into Alcohol Addiction Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Alcohol Addiction Therapeutics Breakdown Data by Type
4.1 Global Alcohol Addiction Therapeutics Historic Revenue by Type (2017-2022)
4.2 Global Alcohol Addiction Therapeutics Forecasted Revenue by Type (2023-2028)
5 Global Alcohol Addiction Therapeutics Breakdown Data by Application
5.1 Global Alcohol Addiction Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Alcohol Addiction Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alcohol Addiction Therapeutics Revenue by Company (2020-2022)
6.2 North America Alcohol Addiction Therapeutics Revenue by Type (2017-2028)
6.3 North America Alcohol Addiction Therapeutics Revenue by Application (2017-2028)
6.4 North America Alcohol Addiction Therapeutics Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Alcohol Addiction Therapeutics Revenue by Company (2020-2022)
7.2 Europe Alcohol Addiction Therapeutics Revenue by Type (2017-2028)
7.3 Europe Alcohol Addiction Therapeutics Revenue by Application (2017-2028)
7.4 Europe Alcohol Addiction Therapeutics Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Alcohol Addiction Therapeutics Revenue by Company (2020-2022)
8.2 Asia Pacific Alcohol Addiction Therapeutics Revenue by Type (2017-2028)
8.3 Asia Pacific Alcohol Addiction Therapeutics Revenue by Application (2017-2028)
8.4 Asia Pacific Alcohol Addiction Therapeutics Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Alcohol Addiction Therapeutics Revenue by Company (2020-2022)
9.2 Latin America Alcohol Addiction Therapeutics Revenue by Type (2017-2028)
9.3 Latin America Alcohol Addiction Therapeutics Revenue by Application (2017-2028)
9.4 Latin America Alcohol Addiction Therapeutics Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Company (2020-2022)
10.2 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Type (2017-2028)
10.3 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Application (2017-2028)
10.4 Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Products and Services
11.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.1.5 AstraZeneca Plc Alcohol Addiction Therapeutics SWOT Analysis
11.1.6 AstraZeneca Plc Recent Developments
11.2 BioCorRx Inc
11.2.1 BioCorRx Inc Company Details
11.2.2 BioCorRx Inc Business Overview
11.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Products and Services
11.2.4 BioCorRx Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.2.5 BioCorRx Inc Alcohol Addiction Therapeutics SWOT Analysis
11.2.6 BioCorRx Inc Recent Developments
11.3 Bionex Pharmaceuticals LLC
11.3.1 Bionex Pharmaceuticals LLC Company Details
11.3.2 Bionex Pharmaceuticals LLC Business Overview
11.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Products and Services
11.3.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.3.5 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics SWOT Analysis
11.3.6 Bionex Pharmaceuticals LLC Recent Developments
11.4 Cerecor Inc
11.4.1 Cerecor Inc Company Details
11.4.2 Cerecor Inc Business Overview
11.4.3 Cerecor Inc Alcohol Addiction Therapeutics Products and Services
11.4.4 Cerecor Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.4.5 Cerecor Inc Alcohol Addiction Therapeutics SWOT Analysis
11.4.6 Cerecor Inc Recent Developments
11.5 Chronos Therapeutics Ltd
11.5.1 Chronos Therapeutics Ltd Company Details
11.5.2 Chronos Therapeutics Ltd Business Overview
11.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Products and Services
11.5.4 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.5.5 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics SWOT Analysis
11.5.6 Chronos Therapeutics Ltd Recent Developments
11.6 Corcept Therapeutics Inc
11.6.1 Corcept Therapeutics Inc Company Details
11.6.2 Corcept Therapeutics Inc Business Overview
11.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Products and Services
11.6.4 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.6.5 Corcept Therapeutics Inc Alcohol Addiction Therapeutics SWOT Analysis
11.6.6 Corcept Therapeutics Inc Recent Developments
11.7 Curemark LLC
11.7.1 Curemark LLC Company Details
11.7.2 Curemark LLC Business Overview
11.7.3 Curemark LLC Alcohol Addiction Therapeutics Products and Services
11.7.4 Curemark LLC Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.7.5 Curemark LLC Alcohol Addiction Therapeutics SWOT Analysis
11.7.6 Curemark LLC Recent Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Products and Services
11.8.4 Eli Lilly and Company Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.8.5 Eli Lilly and Company Alcohol Addiction Therapeutics SWOT Analysis
11.8.6 Eli Lilly and Company Recent Developments
11.9 Ethypharm SA
11.9.1 Ethypharm SA Company Details
11.9.2 Ethypharm SA Business Overview
11.9.3 Ethypharm SA Alcohol Addiction Therapeutics Products and Services
11.9.4 Ethypharm SA Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.9.5 Ethypharm SA Alcohol Addiction Therapeutics SWOT Analysis
11.9.6 Ethypharm SA Recent Developments
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Company Details
11.10.2 H. Lundbeck A/S Business Overview
11.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Products and Services
11.10.4 H. Lundbeck A/S Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.10.5 H. Lundbeck A/S Alcohol Addiction Therapeutics SWOT Analysis
11.10.6 H. Lundbeck A/S Recent Developments
11.11 Heptares Therapeutics Ltd
11.11.1 Heptares Therapeutics Ltd Company Details
11.11.2 Heptares Therapeutics Ltd Business Overview
11.11.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Products and Services
11.11.4 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.11.5 Heptares Therapeutics Ltd Recent Developments
11.12 Indivior Plc
11.12.1 Indivior Plc Company Details
11.12.2 Indivior Plc Business Overview
11.12.3 Indivior Plc Alcohol Addiction Therapeutics Products and Services
11.12.4 Indivior Plc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.12.5 Indivior Plc Recent Developments
11.13 Kinnov Therapeutics SAS
11.13.1 Kinnov Therapeutics SAS Company Details
11.13.2 Kinnov Therapeutics SAS Business Overview
11.13.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Products and Services
11.13.4 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.13.5 Kinnov Therapeutics SAS Recent Developments
11.14 Kyorin Pharmaceutical Co Ltd
11.14.1 Kyorin Pharmaceutical Co Ltd Company Details
11.14.2 Kyorin Pharmaceutical Co Ltd Business Overview
11.14.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Products and Services
11.14.4 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.14.5 Kyorin Pharmaceutical Co Ltd Recent Developments
11.15 Lohocla Research Corp
11.15.1 Lohocla Research Corp Company Details
11.15.2 Lohocla Research Corp Business Overview
11.15.3 Lohocla Research Corp Alcohol Addiction Therapeutics Products and Services
11.15.4 Lohocla Research Corp Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.15.5 Lohocla Research Corp Recent Developments
11.16 Montisera Ltd
11.16.1 Montisera Ltd Company Details
11.16.2 Montisera Ltd Business Overview
11.16.3 Montisera Ltd Alcohol Addiction Therapeutics Products and Services
11.16.4 Montisera Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.16.5 Montisera Ltd Recent Developments
11.17 Omeros Corp
11.17.1 Omeros Corp Company Details
11.17.2 Omeros Corp Business Overview
11.17.3 Omeros Corp Alcohol Addiction Therapeutics Products and Services
11.17.4 Omeros Corp Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.17.5 Omeros Corp Recent Developments
11.18 Opiant Pharmaceuticals Inc
11.18.1 Opiant Pharmaceuticals Inc Company Details
11.18.2 Opiant Pharmaceuticals Inc Business Overview
11.18.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Products and Services
11.18.4 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022)
11.18.5 Opiant Pharmaceuticals Inc Recent Developments
12 Alcohol Addiction Therapeutics Market Dynamics
12.1 Alcohol Addiction Therapeutics Market Trends
12.2 Alcohol Addiction Therapeutics Market Drivers
12.3 Alcohol Addiction Therapeutics Market Challenges
12.4 Alcohol Addiction Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Alcohol Addiction Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CM-1212
Table 3. Key Players of CTDP-002
Table 4. Key Players of A-705253
Table 5. Key Players of ABT-436
Table 6. Key Players of ADX-71441
Table 7. Key Players of Others
Table 8. Global Alcohol Addiction Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Alcohol Addiction Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Alcohol Addiction Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Alcohol Addiction Therapeutics Revenue Market Share by Region (2017-2022)
Table 12. Global Alcohol Addiction Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Alcohol Addiction Therapeutics Market Share by Players (2017-2022)
Table 14. Global Top Alcohol Addiction Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcohol Addiction Therapeutics as of 2021)
Table 15. Ranking of Global Top Alcohol Addiction Therapeutics Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Alcohol Addiction Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Alcohol Addiction Therapeutics Product Solution and Service
Table 19. Date of Key Manufacturers Enter into Alcohol Addiction Therapeutics Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Alcohol Addiction Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2017-2022)
Table 23. Global Alcohol Addiction Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Alcohol Addiction Therapeutics Revenue Market Share by Type (2023-2028)
Table 25. Global Alcohol Addiction Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2017-2022)
Table 27. Global Alcohol Addiction Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2023-2028)
Table 29. North America Alcohol Addiction Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 30. North America Alcohol Addiction Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 31. North America Alcohol Addiction Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 32. North America Alcohol Addiction Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 33. North America Alcohol Addiction Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 34. North America Alcohol Addiction Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 35. North America Alcohol Addiction Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 36. Europe Alcohol Addiction Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 37. Europe Alcohol Addiction Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 38. Europe Alcohol Addiction Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 39. Europe Alcohol Addiction Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 40. Europe Alcohol Addiction Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 41. Europe Alcohol Addiction Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 42. Europe Alcohol Addiction Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Alcohol Addiction Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 44. Asia Pacific Alcohol Addiction Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Alcohol Addiction Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Alcohol Addiction Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Alcohol Addiction Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Alcohol Addiction Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Alcohol Addiction Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 50. Latin America Alcohol Addiction Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 51. Latin America Alcohol Addiction Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 52. Latin America Alcohol Addiction Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 53. Latin America Alcohol Addiction Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 54. Latin America Alcohol Addiction Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 55. Latin America Alcohol Addiction Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 56. Latin America Alcohol Addiction Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 58. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Alcohol Addiction Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 64. AstraZeneca Plc Company Details
Table 65. AstraZeneca Plc Business Overview
Table 66. AstraZeneca Plc Alcohol Addiction Therapeutics Product and Services
Table 67. AstraZeneca Plc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 68. AstraZeneca Plc Alcohol Addiction Therapeutics SWOT Analysis
Table 69. AstraZeneca Plc Recent Developments
Table 70. BioCorRx Inc Company Details
Table 71. BioCorRx Inc Business Overview
Table 72. BioCorRx Inc Alcohol Addiction Therapeutics Product and Services
Table 73. BioCorRx Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 74. BioCorRx Inc Alcohol Addiction Therapeutics SWOT Analysis
Table 75. BioCorRx Inc Recent Developments
Table 76. Bionex Pharmaceuticals LLC Company Details
Table 77. Bionex Pharmaceuticals LLC Business Overview
Table 78. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product and Services
Table 79. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics SWOT Analysis
Table 81. Bionex Pharmaceuticals LLC Recent Developments
Table 82. Cerecor Inc Company Details
Table 83. Cerecor Inc Business Overview
Table 84. Cerecor Inc Alcohol Addiction Therapeutics Product and Services
Table 85. Cerecor Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Cerecor Inc Alcohol Addiction Therapeutics SWOT Analysis
Table 87. Cerecor Inc Recent Developments
Table 88. Chronos Therapeutics Ltd Company Details
Table 89. Chronos Therapeutics Ltd Business Overview
Table 90. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product and Services
Table 91. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 92. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics SWOT Analysis
Table 93. Chronos Therapeutics Ltd Recent Developments
Table 94. Corcept Therapeutics Inc Company Details
Table 95. Corcept Therapeutics Inc Business Overview
Table 96. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product and Services
Table 97. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 98. Corcept Therapeutics Inc Alcohol Addiction Therapeutics SWOT Analysis
Table 99. Corcept Therapeutics Inc Recent Developments
Table 100. Curemark LLC Company Details
Table 101. Curemark LLC Business Overview
Table 102. Curemark LLC Alcohol Addiction Therapeutics Product and Services
Table 103. Curemark LLC Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Curemark LLC Alcohol Addiction Therapeutics SWOT Analysis
Table 105. Curemark LLC Recent Developments
Table 106. Eli Lilly and Company Company Details
Table 107. Eli Lilly and Company Business Overview
Table 108. Eli Lilly and Company Alcohol Addiction Therapeutics Product and Services
Table 109. Eli Lilly and Company Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 110. Eli Lilly and Company Alcohol Addiction Therapeutics SWOT Analysis
Table 111. Eli Lilly and Company Recent Developments
Table 112. Ethypharm SA Company Details
Table 113. Ethypharm SA Business Overview
Table 114. Ethypharm SA Alcohol Addiction Therapeutics Product and Services
Table 115. Ethypharm SA Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 116. Ethypharm SA Alcohol Addiction Therapeutics SWOT Analysis
Table 117. Ethypharm SA Recent Developments
Table 118. H. Lundbeck A/S Company Details
Table 119. H. Lundbeck A/S Business Overview
Table 120. H. Lundbeck A/S Alcohol Addiction Therapeutics Product and Services
Table 121. H. Lundbeck A/S Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 122. H. Lundbeck A/S Alcohol Addiction Therapeutics SWOT Analysis
Table 123. H. Lundbeck A/S Recent Developments
Table 124. Heptares Therapeutics Ltd Company Details
Table 125. Heptares Therapeutics Ltd Business Overview
Table 126. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product and Services
Table 127. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 128. Heptares Therapeutics Ltd Recent Developments
Table 129. Indivior Plc Company Details
Table 130. Indivior Plc Business Overview
Table 131. Indivior Plc Alcohol Addiction Therapeutics Product and Services
Table 132. Indivior Plc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 133. Indivior Plc Recent Developments
Table 134. Kinnov Therapeutics SAS Company Details
Table 135. Kinnov Therapeutics SAS Business Overview
Table 136. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product and Services
Table 137. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 138. Kinnov Therapeutics SAS Recent Developments
Table 139. Kyorin Pharmaceutical Co Ltd Company Details
Table 140. Kyorin Pharmaceutical Co Ltd Business Overview
Table 141. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product and Services
Table 142. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 143. Kyorin Pharmaceutical Co Ltd Recent Developments
Table 144. Lohocla Research Corp Company Details
Table 145. Lohocla Research Corp Business Overview
Table 146. Lohocla Research Corp Alcohol Addiction Therapeutics Product and Services
Table 147. Lohocla Research Corp Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 148. Lohocla Research Corp Recent Developments
Table 149. Montisera Ltd Company Details
Table 150. Montisera Ltd Business Overview
Table 151. Montisera Ltd Alcohol Addiction Therapeutics Product and Services
Table 152. Montisera Ltd Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 153. Montisera Ltd Recent Developments
Table 154. Omeros Corp Company Details
Table 155. Omeros Corp Business Overview
Table 156. Omeros Corp Alcohol Addiction Therapeutics Product and Services
Table 157. Omeros Corp Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 158. Omeros Corp Recent Developments
Table 159. Opiant Pharmaceuticals Inc Company Details
Table 160. Opiant Pharmaceuticals Inc Business Overview
Table 161. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product and Services
Table 162. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Revenue in Alcohol Addiction Therapeutics Business (2017-2022) & (US$ Million)
Table 163. Opiant Pharmaceuticals Inc Recent Developments
Table 164. Alcohol Addiction Therapeutics Market Trends
Table 165. Alcohol Addiction Therapeutics Market Drivers
Table 166. Alcohol Addiction Therapeutics Market Challenges
Table 167. Alcohol Addiction Therapeutics Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alcohol Addiction Therapeutics Sales Market Share by Type: 2021 VS 2028
Figure 2. CM-1212 Features
Figure 3. CTDP-002 Features
Figure 4. A-705253 Features
Figure 5. ABT-436 Features
Figure 6. ADX-71441 Features
Figure 7. Others Features
Figure 8. Global Alcohol Addiction Therapeutics Sales Market Share by Application: 2021 VS 2028
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Alcohol Addiction Therapeutics Report Years Considered
Figure 13. Global Alcohol Addiction Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Alcohol Addiction Therapeutics Market Size 2017-2028 (US$ Million)
Figure 15. Global Alcohol Addiction Therapeutics Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Alcohol Addiction Therapeutics Revenue Market Share by Region in 2017 VS 2022
Figure 17. Global Top 10 Alcohol Addiction Therapeutics Countries Ranking by Market Size (US$ Million) in 2021
Figure 18. Global Alcohol Addiction Therapeutics Market Share by Players in 2021
Figure 19. Global Top Alcohol Addiction Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alcohol Addiction Therapeutics as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Alcohol Addiction Therapeutics Revenue in 2021
Figure 21. North America Alcohol Addiction Therapeutics Revenue Market Share by Company in 2021
Figure 22. North America Alcohol Addiction Therapeutics Revenue Market Share by Type (2017-2028)
Figure 23. North America Alcohol Addiction Therapeutics Revenue Market Share by Application (2017-2028)
Figure 24. North America Alcohol Addiction Therapeutics Revenue Share by Country (2017-2028)
Figure 25. U.S. Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 26. Canada Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 27. Europe Alcohol Addiction Therapeutics Revenue Market Share by Company in 2021
Figure 28. Europe Alcohol Addiction Therapeutics Revenue Market Share by Type (2017-2028)
Figure 29. Europe Alcohol Addiction Therapeutics Revenue Market Share by Application (2017-2028)
Figure 30. Europe Alcohol Addiction Therapeutics Revenue Share by Country (2017-2028)
Figure 31. Germany Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 32. France Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 33. U.K. Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 34. Italy Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 35. Russia Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Alcohol Addiction Therapeutics Revenue Market Share by Company in 2021
Figure 37. Asia Pacific Alcohol Addiction Therapeutics Revenue Market Share by Type (2017-2028)
Figure 38. Asia Pacific Alcohol Addiction Therapeutics Revenue Market Share by Application (2017-2028)
Figure 39. Asia Pacific Alcohol Addiction Therapeutics Revenue Share by Region (2017-2028)
Figure 40. China Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 41. Japan Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 42. South Korea Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 43. India Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 44. Australia Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 45. Taiwan Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 46. Indonesia Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 47. Thailand Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 48. Malaysia Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 49. Philippines Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 50. Vietnam Alcohol Addiction Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 51. Latin America Alcohol Addiction Therapeutics Revenue Market Share by Company in 2021
Figure 52. Latin America Alcohol Addiction Therapeutics Revenue Market Share by Type (2017-2028)
Figure 53. Latin America Alcohol Addiction Therapeutics Revenue Market Share by Application (2017-2028)
Figure 54. Latin America Alcoh
  • Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......
  • Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 110
    Report Overview: Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......
  • Global Epilepsy Therapeutics Market Research Report 2023
    Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Cephalon - Novartis - Pfizer - Johnson & Johnson - GlaxoSmithKline - Sanofi - Sunovion Pharmaceuticals......
  • Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Autism Spectrum Disorder market: According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......
  • Global Autism Spectrum Disorder Market Status and Outlook 2023-2028
    Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 109
    Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......
  • Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Epilepsy Therapeutics market: According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years. Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......
  • Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Gabapentin market: According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......
  • 2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel
    Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 89
    This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Aut......
  • Global Gabapentin Market Insights, Forecast to 2029
    Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 112
    Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs